On silico peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactions

Nature Medicine

Volumn 18, Issue 9, 2012, Pages 1434-1440

  Price, Jordan V ^a   Tangsombatvisit, Stephanie ^a   Xu, Guangyu ^b   Yu, Jiangtao ^b   Levy, Dan ^c   Baechler, Emily C ^d   Gozani, Or ^c   Varma, Madoo ^b   Utz, Paul J ^a   Liu, Chih Long ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INTEL CORPORATION   (United States)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HISTONE H2B; LYSINE; METHYLTRANSFERASE; SILICON; EPITOPE; HISTONE; PEPTIDE; PHOSPHOTRANSFERASE;

AMINO ACID SEQUENCE; ARTICLE; DISEASE SEVERITY; EPITOPE MAPPING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SYSTEMIC LUPUS ERYTHEMATOSUS; COMPUTER SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HOSPITAL INFORMATION SYSTEM; HUMAN; INSTRUMENTATION; METABOLISM; METHODOLOGY; MICROARRAY ANALYSIS; MOLECULAR GENETICS; PHOSPHORYLATION; PROTEIN ANALYSIS;

AMINO ACID SEQUENCE; COMPUTER SYSTEMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HISTONES; HUMANS; METHYLTRANSFERASES; MICROARRAY ANALYSIS; MOLECULAR SEQUENCE DATA; PEPTIDES; PHOSPHORYLATION; PHOSPHOTRANSFERASES; POINT-OF-CARE SYSTEMS; PROTEIN INTERACTION MAPPING; PROTEOMICS;

EID: 84868666605     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2913     Document Type: Article

References (39)

1. Cortese, D.A. A vision of individualized medicine in the context of global health. Clin. Pharmacol. Ther. 82, 491-493 (2007).
2. Robinson, W.H. et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 8, 295-301 (2002).
3. Robinson, W.H. et al. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat. Biotechnol. 21, 1033-1039 (2003).
4. Neuman de Vegvar, H.E. et al. Microarray profiling of antibody responses against simian-human immunodeficiency virus: postchallenge convergence of reactivities independent of host histocompatibility type and vaccine regimen. J. Virol. 77, 11125-11138 (2003).
5. Chan, S.M., Ermann, J., Su, L., Fathman, C.G. & Utz, P.J. Protein microarrays for multiplex analysis of signal transduction pathways. Nat. Med. 10, 1390-1396 (2004).
6. Kattah, M.G., Coller, J., Cheung, R.K., Oshidary, N. & Utz, P.J. HIT: a versatile proteomics platform for multianalyte phenotyping of cytokines, intracellular proteins and surface molecules. Nat. Med. 14, 1284-1289 (2008).
7. Haab, B.B. Antibody arrays in cancer research. Mol. Cell. Proteomics 4, 377-383 (2005).
8. Ray, S. et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 13, 1359-1362 (2007).
9. Britschgi, M. et al. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease. Proc. Natl. Acad. Sci. USA 106, 12145-12150 (2009).
10. Vigh-Conrad, K.A., Conrad, D.F. & Preuss, D. A protein allergen microarray detects specific IgE to pollen surface, cytoplasmic, and commercial allergen extracts. PLoS ONE 5, e10174 (2010).
11. Bailey, R.C. Grand challenge commentary: informative diagnostics for personalized medicine. Nat. Chem. Biol. 6, 857-859 (2010).
12. Fodor, S.P. et al. Light-directed, spatially addressable parallel chemical synthesis. Science 251, 767-773 (1991).
13. Gao, X., Zhou, X. & Gulari, E. Light directed massively parallel on-chip synthesis of peptide arrays with t-Boc chemistry. Proteomics 3, 2135-2141 (2003).
14. Shin, D.S. et al. Automated maskless photolithography system for peptide microarray synthesis on a chip. J. Comb. Chem. 12, 463-471 (2010).
15. Khorasanizadeh, S. The nucleosome: from genomic organization to genomic regulation. Cell 116, 259-272 (2004).
16. Kouzarides, T. Chromatin modifications and their function. Cell 128, 693-705 (2007).
17. Monestier, M., Decker, P., Briand, J.P., Gabriel, J.L. & Muller, S. Molecular and structural properties of three autoimmune IgG monoclonal antibodies to histone H2B. J. Biol. Chem. 275, 13558-13563 (2000).
18. van Bavel, C.C. et al. Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies. Mol. Immunol. 47, 511-516 (2009).
19. Barone, A.D. et al. Photolithographic synthesis of high-density oligonucleotide probe arrays. Nucleosides Nucleotides Nucleic Acids 20, 525-531 (2001).
20. Lee, M.S. & Kerns, E.H. LC/MS applications in drug development. Mass Spectrom. Rev. 18, 187-279 (1999).
21. Dhayalan, A., Kudithipudi, S., Rathert, P. & Jeltsch, A. Specificity analysis-based identification of new methylation targets of the SET7/9 protein lysine methyltransferase. Chem. Biol. 18, 111-120 (2011).
22. Cheung, W.L. et al. Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 113, 507-517 (2003).
23. von Mühlen, C.A. & Tan, E.M. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin. Arthritis Rheum. 24, 323-358 (1995).
24. Baechler, E.C. et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 100, 2610-2615 (2003).
25. Bauer, J.W. et al. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med. 3, e491 (2006).
26. Obermoser, G. & Pascual, V. The interferon-α signature of systemic lupus erythematosus. Lupus 19, 1012-1019 (2010).
27. Dieker, J.W. et al. Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. Arthritis Rheum. 56, 1921-1933 (2007).
28. van Bavel, C.C. et al. Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus. Ann. Rheum. Dis. 70, 201-207 (2011).
29. Petri, M. Hopkins Lupus Cohort. 1999 update. Rheum. Dis. Clin. North Am. 26, 199-213, 5 (2000).
30. Tusher, V.G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121 (2001).
31. Baker, M. Upping the ante on antibodies. Nat. Biotechnol. 23, 1065-1072 (2005).
32. Levy, D. et al. Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling. Nat. Immunol. 12, 29-36 (2011).
33. Yoo, C.B. & Jones, P.A. Epigenetic therapy of cancer: past, present and future. Nat. Rev. Drug Discov. 5, 37-50 (2006).
34. Volta, U. et al. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J. Clin. Gastroenterol. 44, 186-190 (2010).
35. Lee, D.M. & Schur, P.H. Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann. Rheum. Dis. 62, 870-874 (2003).
36. Hoffman, I.E. et al. Diagnostic performance and predictive value of rheumatoid factor, anti-citrullinated peptide antibodies, and the HLA shared epitope for diagnosis of rheumatoid arthritis. Clin. Chem. 51, 261-263 (2005).
37. Garren, H. et al. Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis. Ann. Neurol. 63, 611-620 (2008).
38. Liskamp, R.M.J., Rijkers, D.T.S., Kruijtzer, J.A.W. & Kemmink, J. Peptides and proteins as a continuing exciting source of inspiration for peptidomimetics. ChemBioChem 12, 1626-1653 (2011).
39. Gaster, R.S., Hall, D.A. & Wang, S.X. nanoLAB: an ultraportable, handheld diagnostic laboratory for global health. Lab Chip 11, 950-956 (2011).